glp-1 obesity drug news today october 23 2025 New Daily Weight Loss Pill Aims to Take on Ozempic GLP-1 Agonists Market Report 2025-2033,

The recent studies have explored the physiological effects of GLP-1RA on body organs, establishing them as a potential therapeutic option for a wide range of diseases

As mentioned, GLP-1RAs are increasingly used in the treatment of T2MD owing to their following advantages: lowering of the levels of blood glucose, reducing body weight, improving the function of islet, and exerting potential cardiovascular benefits (206)

Yes, both drugs share certain common side effects, including nausea, vomiting, diarrhoea, constipation, and appetite loss

doi:10.3389/fendo.2020.597583 8

When an operator provides tutorials, demo modes, and responsive support channels, players can test options without pressure